Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Indian Immunologicals Limited - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Indian Immunologicals Limited - Product Pipeline Review - 2016', provides an overview of the Indian Immunologicals Limited's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Indian Immunologicals Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Indian Immunologicals Limited - The report provides overview of Indian Immunologicals Limited including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Indian Immunologicals Limited's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Indian Immunologicals Limited's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Indian Immunologicals Limited's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Indian Immunologicals Limited - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Indian Immunologicals Limited's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Indian Immunologicals Limited Snapshot 5 Indian Immunologicals Limited Overview 5 Key Information 5 Key Facts 5 Indian Immunologicals Limited - Research and Development Overview 6 Key Therapeutic Areas 6 Indian Immunologicals Limited - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Indian Immunologicals Limited - Pipeline Products Glance 11 Indian Immunologicals Limited - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Indian Immunologicals Limited - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Indian Immunologicals Limited - Unknown Stage Pipeline Products 13 Unknown Products/Combination Treatment Modalities 13 Indian Immunologicals Limited - Drug Profiles 14 (diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis (wholl cell) + tetanus) (pentavalent) vaccine 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 chikungunya vaccine 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 human papillomavirus [serotypes 16, 18] vaccine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Japanese encephalitis vaccine 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Alphavirus vaccine 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 flavivirus vaccine 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 picornavirus vaccine 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Vaccine for Undisclosed Indication 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Indian Immunologicals Limited - Pipeline Analysis 22 Indian Immunologicals Limited - Pipeline Products by Target 22 Indian Immunologicals Limited - Pipeline Products by Route of Administration 23 Indian Immunologicals Limited - Pipeline Products by Molecule Type 24 Indian Immunologicals Limited - Recent Pipeline Updates 25 Indian Immunologicals Limited - Dormant Projects 26 Indian Immunologicals Limited - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables Indian Immunologicals Limited, Key Information 5 Indian Immunologicals Limited, Key Facts 5 Indian Immunologicals Limited - Pipeline by Indication, 2016 7 Indian Immunologicals Limited - Pipeline by Stage of Development, 2016 8 Indian Immunologicals Limited - Monotherapy Products in Pipeline, 2016 9 Indian Immunologicals Limited - Combination Treatment Modalities in Pipeline, 2016 10 Indian Immunologicals Limited - Phase I, 2016 11 Indian Immunologicals Limited - Preclinical, 2016 12 Indian Immunologicals Limited - Unknown, 2016 13 Indian Immunologicals Limited - Pipeline by Target, 2016 22 Indian Immunologicals Limited - Pipeline by Route of Administration, 2016 23 Indian Immunologicals Limited - Pipeline by Molecule Type, 2016 24 Indian Immunologicals Limited - Recent Pipeline Updates, 2016 25 Indian Immunologicals Limited - Dormant Developmental Projects,2016 26 Indian Immunologicals Limited, Other Locations 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.